Holmes D

References (3)

Title : The dipeptidyl peptidase 4 inhibitor vildagliptin does not accentuate glibenclamide-induced hypoglycemia but reduces glucose-induced glucagon-like peptide 1 and gastric inhibitory polypeptide secretion - El-Ouaghlidi_2007_J.Clin.Endocrinol.Metab_92_4165
Author(s) : El-Ouaghlidi A , Rehring E , Holst JJ , Schweizer A , Foley J , Holmes D , Nauck MA
Ref : J Clinical Endocrinology Metab , 92 :4165 , 2007
Abstract :
PubMedSearch : El-Ouaghlidi_2007_J.Clin.Endocrinol.Metab_92_4165
PubMedID: 17698900

Title : Improved glycaemic control with dipeptidyl peptidase-4 inhibition in patients with type 2 diabetes: vildagliptin (LAF237) dose response - Ristic_2005_Diabetes.Obes.Metab_7_692
Author(s) : Ristic S , Byiers S , Foley J , Holmes D
Ref : Diabetes Obes Metab , 7 :692 , 2005
Abstract :
PubMedSearch : Ristic_2005_Diabetes.Obes.Metab_7_692
PubMedID: 16219012

Title : Residential pesticide use during pregnancy among a cohort of urban minority women - Whyatt_2002_Environ.Health.Perspect_110_507
Author(s) : Whyatt RM , Camann DE , Kinney PL , Reyes A , Ramirez J , Dietrich J , Diaz D , Holmes D , Perera FP
Ref : Environmental Health Perspectives , 110 :507 , 2002
Abstract :
PubMedSearch : Whyatt_2002_Environ.Health.Perspect_110_507
PubMedID: 12003754